Profil
Michael J.
Pontecorvo is currently the Vice President of Clinical Development at Avid Radiopharmaceuticals, Inc. He previously worked as the Vice President of Clinical Research at DOV Pharmaceutical, Inc. and as a Principal at Janssen Pharmaceutica NV.
He obtained his undergraduate degree from Indiana University.
Aktive Positionen von Michael J. Pontecorvo
| Unternehmen | Position | Beginn |
|---|---|---|
Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a molecular imaging company that develops radioactive tracers and diagnostics | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael J. Pontecorvo
| Unternehmen | Position | Ende |
|---|---|---|
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Technik-/Wissenschafts-/F&E-Leiter | - |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Corporate Officer/Principal | - |
Ausbildung von Michael J. Pontecorvo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Commercial Services |
Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a molecular imaging company that develops radioactive tracers and diagnostics | Health Technology |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
















